Stryker Corp
NYSE:SYK
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
287.87
390.14
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SYK stock under the Base Case scenario is 287.61 USD. Compared to the current market price of 384.85 USD, Stryker Corp is Overvalued by 25%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Stryker Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SYK cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Stryker Corp
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Stryker Corporation, a prominent player in the global medical technology landscape, has carved out a reputation for innovation and reliability since its founding in 1941. Specializing in developing and manufacturing a diverse range of products, Stryker's offerings span surgical equipment, implantable devices, and medical instruments, all designed to enhance patient care and improve clinical outcomes. Fueled by a commitment to quality and continuous improvement, the company invests heavily in research and development, leading the way with cutting-edge technologies like robotic surgical systems and advanced orthopedic solutions. The company’s strong market position is bolstered by its strategi...
Stryker Corporation, a prominent player in the global medical technology landscape, has carved out a reputation for innovation and reliability since its founding in 1941. Specializing in developing and manufacturing a diverse range of products, Stryker's offerings span surgical equipment, implantable devices, and medical instruments, all designed to enhance patient care and improve clinical outcomes. Fueled by a commitment to quality and continuous improvement, the company invests heavily in research and development, leading the way with cutting-edge technologies like robotic surgical systems and advanced orthopedic solutions. The company’s strong market position is bolstered by its strategic acquisitions, which not only expand its product portfolio but also deepen its penetration into key medical segments, allowing Stryker to sustain impressive growth rates.
For investors, Stryker represents a compelling opportunity in the healthcare sector, driven by the increasing demand for advanced medical solutions in an aging global population. With a presence in over 100 countries, Stryker's diversified revenue streams reduce risk and enhance resilience against market fluctuations. The company consistently delivers solid financial performance, characterized by robust margins and healthy cash flows, which it strategically reinvests to fuel future growth. Furthermore, its strong commitment to sustainability and corporate responsibility positions Stryker favorably in a market increasingly concerned with ethical practices. As the healthcare industry continues to evolve, Stryker’s innovative edge and solid fundamentals make it a captivating prospect for investors seeking long-term stability and growth.
Stryker Corporation is a prominent player in the medical technology sector and operates through several core business segments. These segments reflect the company's focus on innovative products and solutions for healthcare. The main business segments of Stryker Corporation include:
-
Orthopedics: This segment focuses on products related to orthopedic surgery, including joint replacement systems (hip, knee, and shoulder), trauma implants, and orthopedic surgical instruments. Stryker is known for its advancements in minimally invasive surgical techniques and its comprehensive portfolio that includes robotic-assisted surgery.
-
Medical and Surgical Equipment: This segment includes a wide range of products such as surgical instruments, endoscopy equipment, and interventional radiology devices. Stryker offers solutions that enhance surgical processes, hospital efficiency, and patient safety.
-
Neurotechnology and Spine: Stryker’s neurotechnology division focuses on products for cranial and spinal surgery, including implants, surgical instruments, and diagnostic equipment. The spine segment covers devices used for spinal repair and rehabilitation.
-
Surgical Robotics: This is a growing area for Stryker, incorporating robotic-assisted technologies that aim to improve surgical precision and patient outcomes. The Mako robotic surgery system is a significant product in this category, primarily used in orthopedic surgeries.
-
Rehabilitation and Acute Care: Under this segment, Stryker provides a range of products designed for post-operative care, including hospital beds, stretchers, and other patient handling equipment that facilitates recovery and mobility.
These segments reflect Stryker's commitment to innovation and the delivery of high-quality healthcare solutions, contributing to its strong position in the medical technology industry. The company continuously invests in research and development to introduce new products and enhance existing ones to meet the evolving needs of healthcare professionals and patients.
Stryker Corporation, a leading medical technology company, has several unique competitive advantages that distinguish it from its rivals in the industry:
-
Innovative Product Portfolio: Stryker invests heavily in research and development, leading to a diverse range of innovative products in orthopedics, surgical equipment, and communications technology. This commitment to innovation helps Stryker consistently launch cutting-edge solutions that meet the evolving needs of healthcare providers.
-
Strong Brand Reputation: Stryker has built a solid reputation for quality and reliability in its products. This brand trust is invaluable in the medical field, where the stakes are high, and providers are more likely to choose reliable partners for their equipment.
-
Focus on Customer Relationships: Stryker emphasizes building long-term relationships with hospitals and healthcare systems. Their sales representatives often provide training and support, which adds value beyond the initial sale and fosters customer loyalty.
-
Robust Global Presence: With a strong international footprint, Stryker benefits from a diversified geographical revenue stream. This global reach allows the company to tap into emerging markets and reduce dependency on any single region.
-
Strong Financial Position: Stryker maintains a healthy balance sheet with strong cash flows, enabling it to invest in new technologies, pursue acquisitions, and weather economic fluctuations better than many competitors.
-
Acquisition Strategy: Stryker has a successful track record of strategic acquisitions to enhance its product offerings and market position. These acquisitions often bring in new technologies and capabilities that strengthen its portfolio.
-
Employee Talent and Culture: Stryker invests in attracting and retaining top talent, fostering a culture of innovation and quality. This strong workforce contributes significantly to the company’s adaptability and continuous improvement.
-
Regulatory Compliance and Quality Control: Stryker’s commitment to meeting rigorous regulatory standards helps ensure product safety and efficacy, giving it an edge in competitive tenders and contracts.
-
Digital Health Integration: With increasing trends towards digital and connected healthcare solutions, Stryker's investment in digital health technologies positions it favorably against competitors who may not be as advanced in this area.
These competitive advantages position Stryker Corporation effectively in the medical technology marketplace, allowing it to maintain a leadership role and create sustained shareholder value.
Stryker Corporation, a leading medical technology firm, faces several risks and challenges that could impact its operations and performance in the near future. These can be categorized into various areas:
1. Regulatory Challenges
- Compliance with Medical Regulations: As a company operating in the medical device sector, Stryker must comply with stringent regulations from authorities like the FDA in the U.S. and CE Mark requirements in Europe. Any changes in regulations or delays in product approvals can impact market entry and profitability.
2. Market Competition
- Intense Competition: The medical technology industry is highly competitive, with numerous players like Medtronic, Zimmer Biomet, and Johnson & Johnson. Innovations from competitors can rapidly change market dynamics.
- Pricing Pressure: As healthcare providers look to reduce costs, Stryker may face pressure to lower prices, which could affect margins.
3. Supply Chain Disruptions
- Global Supply Chain Issues: Ongoing disruptions due to geopolitical situations, pandemics, or trade regulations could affect the availability and cost of raw materials and components necessary for manufacturing.
- Logistical Challenges: Disruptions in logistics can delay product delivery to customers, impacting sales and customer satisfaction.
4. Technological Advancements
- Need for Continuous Innovation: The medical technology field is rapidly evolving. Stryker must continually invest in research and development to stay ahead of technological trends and meet changing healthcare needs.
- Integration of AI and Robotics: Increased use of artificial intelligence and robotic surgery may require Stryker to adapt quickly or risk being left behind by competitors that are faster to innovate.
5. Economic Factors
- Recession Risks: Economic downturns can lead to reduced healthcare spending, affecting sales of medical devices.
- Healthcare Budget Constraints: Hospital budgets may be tightened, affecting purchasing decisions for new equipment.
6. Talent Acquisition and Retention
- Skilled Labor Shortage: Attracting and retaining skilled workers in engineering, sales, and manufacturing is crucial to Stryker's operations. Increased competition for talent in the healthcare technology sector poses a risk.
7. Product Liability Risks
- Litigation Risks: The medical industry is prone to litigation risks associated with product recalls, malfunctions, or adverse effects. Legal challenges could adversely impact Stryker’s reputation and finances.
8. Reputation Management
- Quality Control: Maintaining product quality is vital for brand strength. Any high-profile issues related to product quality could damage Stryker's reputation and result in significant financial impacts.
9. Adoption of New Technologies
- Resistance to Change: Healthcare professionals may be resistant to adopting new devices and technologies, which could slow down the growth of certain new product lines.
10. Global Health Issues
- Pandemics and Public Health Crises: Future health crises could disrupt production, supply chains, and customer operations, affecting demand for certain medical devices.
By proactively addressing these challenges and risks, Stryker can continue to innovate and maintain its competitive edge in the dynamic medical technology market.
Revenue & Expenses Breakdown
Stryker Corp
Balance Sheet Decomposition
Stryker Corp
Current Assets | 14.7B |
Cash & Short-Term Investments | 4.7B |
Receivables | 3.7B |
Other Current Assets | 6.3B |
Non-Current Assets | 29.2B |
PP&E | 3.9B |
Intangibles | 21.3B |
Other Non-Current Assets | 3.9B |
Current Liabilities | 7.7B |
Accounts Payable | 1.3B |
Accrued Liabilities | 3.5B |
Other Current Liabilities | 2.9B |
Non-Current Liabilities | 16B |
Long-Term Debt | 13.3B |
Other Non-Current Liabilities | 2.7B |
Earnings Waterfall
Stryker Corp
Revenue
|
22B
USD
|
Cost of Revenue
|
-7.9B
USD
|
Gross Profit
|
14B
USD
|
Operating Expenses
|
-9.2B
USD
|
Operating Income
|
4.8B
USD
|
Other Expenses
|
-1.2B
USD
|
Net Income
|
3.6B
USD
|
Free Cash Flow Analysis
Stryker Corp
USD | |
Free Cash Flow | USD |
Stryker reported robust organic sales growth of 11.5% in Q3 2024, driven by strong performances in MedSurg, Neurotechnology, and Orthopaedics. Adjusted EPS reached $2.87, up 16.7% year-over-year. Management now anticipates full-year organic sales growth of 9.5% to 10%, alongside adjusted EPS guidance of $12 to $12.10. The company highlighted successful M&A activities, strengthening its portfolio and addressing emerging healthcare needs. Stryker also targets 200 basis points of margin expansion by 2025, focusing on operational efficiencies amid steady demand for robotic-assisted procedures and ongoing product innovations.
What is Earnings Call?
SYK Profitability Score
Profitability Due Diligence
Stryker Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Stryker Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
SYK Solvency Score
Solvency Due Diligence
Stryker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Stryker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SYK Price Targets Summary
Stryker Corp
According to Wall Street analysts, the average 1-year price target for SYK is 409.65 USD with a low forecast of 373.7 USD and a high forecast of 472.5 USD.
Dividends
Current shareholder yield for SYK is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SYK Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Stryker Corp. engages in the provision of medical technology products and services. The company is headquartered in Portage, Michigan and currently employs 46,000 full-time employees. The firm offers products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine that help improve patient and hospital outcomes. Its products are sold in approximately 75 countries through Company-owned subsidiaries and branches, as well as, third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a range of medical specialties. Its business segments include MedSurg and Neurotechnology and Orthopaedics and Spine. Its subsidiaries include Alcott Indemnity Company, Arrinex, Inc., Berchtold Corporation, and BioMimetic Therapeutics, LLC.
Contact
IPO
Employees
Officers
The intrinsic value of one SYK stock under the Base Case scenario is 287.61 USD.
Compared to the current market price of 384.85 USD, Stryker Corp is Overvalued by 25%.